UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Expert opinion on drug safety, ISSN 1474-0338, 07/2016, Volume 15, Issue 7, pp. 925 - 935
sunitinib | Bisphosphonate | everolimus | temsirolimus | aflibercept | Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) | bevacizumab | Osteonecrosis of the jaw (ONJ) | Medication-Related Osteonecrosis of the Jaw (MRONJ) | denosumab | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Jaw Diseases - diagnosis | Osteonecrosis - diagnosis | Risk Assessment - methods | Humans | Antineoplastic Agents - administration & dosage | Osteonecrosis - pathology | Molecular Targeted Therapy | Neoplasms - drug therapy | Jaw Diseases - chemically induced | Angiogenesis Inhibitors - administration & dosage | Jaw Diseases - pathology | Antineoplastic Agents - adverse effects | Bisphosphonate-Associated Osteonecrosis of the Jaw - pathology | Bisphosphonate-Associated Osteonecrosis of the Jaw - diagnosis | Quality of Life | Bisphosphonate-Associated Osteonecrosis of the Jaw - etiology | Osteonecrosis - chemically induced | Angiogenesis Inhibitors - adverse effects | Index Medicus
Journal Article
Journal of cranio-maxillo-facial surgery, ISSN 1010-5182, 2010, Volume 39, Issue 4, pp. 272 - 277
Surgery | Osteoporosis | Bisphosphonate | BRONJ | Bisphosphonate-related osteonecrosis of the jaw | Osteonecrosis | ONJ | Oral | Necrosis | Life Sciences & Biomedicine | Dentistry, Oral Surgery & Medicine | Science & Technology | Osteoporosis. Osteomalacia. Paget disease | Otorhinolaryngology. Stomatology | Pharmacology. Drug treatments | Bones, joints and connective tissue. Antiinflammatory agents | Diseases of the osteoarticular system | Biological and medical sciences | Medical sciences | Bone Density Conservation Agents - adverse effects | Administration, Oral | Humans | Osteoporosis - drug therapy | Diphosphonates - administration & dosage | Bone Density Conservation Agents - administration & dosage | Oral Surgical Procedures | Contraindications | Dose-Response Relationship, Drug | Jaw Diseases - chemically induced | Time Factors | Osteonecrosis - chemically induced | Diphosphonates - adverse effects | Surgery, Plastic | Oncology, Experimental | Phosphonates | Development and progression | Bones | Metastasis | Research | Universities and colleges | Cancer | Index Medicus | Dentistry
Journal Article
Cochrane library, ISSN 1469-493X, 02/2016, Volume 2016, Issue 2, pp. CD008455 - CD008455
Mouthwashes | Oral & maxillofacial surgery | Standard of Care | Combined Modality Therapy | Osteonecrosis | ORAL HEALTH | Dentistry & oral health | Randomized Controlled Trials as Topic | Time Factors | Anti‐Bacterial Agents | Child health | Bisphosphonate‐Associated Osteonecrosis of the Jaw | Pain Measurement | Medicine General & Introductory Medical Sciences | Hyperbaric Oxygenation | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Anti-Bacterial Agents - therapeutic use | Humans | Hyperbaric Oxygenation - methods | Bisphosphonate-Associated Osteonecrosis of the Jaw - therapy | Combined Modality Therapy - methods | Mouthwashes - therapeutic use | Bisphosphonate-Associated Osteonecrosis of the Jaw - surgery | Index Medicus
Journal Article
Journal of cranio-maxillo-facial surgery, ISSN 1010-5182, 2013, Volume 42, Issue 6, pp. 744 - 750
Surgery | Zoledronic acid | Osteonecrosis of the jaws | Bisphosphonates | Life Sciences & Biomedicine | Dentistry, Oral Surgery & Medicine | Science & Technology | Molar - surgery | Injections, Intravenous | Rats, Wistar | Imidazoles - administration & dosage | Male | Maxilla - surgery | Tooth Extraction - adverse effects | Maxilla - pathology | Diphosphonates - adverse effects | Disease Models, Animal | Bone Resorption - etiology | Osteoclasts - pathology | Bone Density Conservation Agents - adverse effects | Imidazoles - adverse effects | Abscess - etiology | Alveolar Process - pathology | Injections, Intraperitoneal | Osteosclerosis - etiology | Rats | Diphosphonates - administration & dosage | Bone Density Conservation Agents - administration & dosage | Random Allocation | Bone Density - drug effects | Abscess - pathology | Animals | Bisphosphonate-Associated Osteonecrosis of the Jaw - pathology | Osteosclerosis - pathology | Bone Resorption - pathology | Alveolar Process - blood supply | Bisphosphonate-Associated Osteonecrosis of the Jaw - etiology | Maxilla - blood supply | Bones | Necrosis | Index Medicus | Dentistry
Journal Article
Oral diseases, ISSN 1354-523X, 09/2012, Volume 18, Issue 6, pp. 621 - 623
Life Sciences & Biomedicine | Dentistry, Oral Surgery & Medicine | Science & Technology | Bisphosphonate-Associated Osteonecrosis of the Jaw - classification | Diagnosis, Differential | Bone Density Conservation Agents - adverse effects | Biopsy | Humans | Bisphosphonate-Associated Osteonecrosis of the Jaw - diagnosis | Terminology as Topic | Diphosphonates - administration & dosage | Decision Trees | Bones | Necrosis | Dentistry | Letter to the Editor
Journal Article
Bone (New York, N.Y.), ISSN 8756-3282, 04/2007, Volume 40, Issue 4, pp. 828 - 834
Prevention | Long-term therapy | Antiinfectious treatment | Bisphosphonate-related osteonecrosis of the bone | Invasion of pathogens | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Biological and medical sciences | Vascular bone diseases | Medical sciences | Pharmacology. Drug treatments | Bones, joints and connective tissue. Antiinflammatory agents | Diseases of the osteoarticular system | Osteonecrosis - etiology | Bone Density Conservation Agents - adverse effects | Humans | Imidazoles - adverse effects | Jaw Diseases - etiology | Jaw Diseases - prevention & control | Middle Aged | Risk Factors | Male | Osteonecrosis - pathology | Switzerland | Jaw Diseases - pathology | Time Factors | Adult | Female | Aged | Osteonecrosis - prevention & control | Diphosphonates - adverse effects | Index Medicus
Journal Article
Lasers in medical science, ISSN 0268-8921, 8/2016, Volume 31, Issue 6, pp. 1261 - 1272
Neoplasm | Osteoporosis | Quantum Optics | Medicine & Public Health | Optics, Optoelectronics, Plasmonics and Optical Devices | Laser Technology, Photonics | Bisphosphonate-related osteonecrosis of the jaw | Dentistry | Neoplasm metastasis | Medicine/Public Health, general | Laser therapy | Engineering | Life Sciences & Biomedicine | Technology | Engineering, Biomedical | Surgery | Science & Technology | Anti-Bacterial Agents - therapeutic use | Lasers, Solid-State - therapeutic use | Low-Level Light Therapy - methods | Humans | Bisphosphonate-Associated Osteonecrosis of the Jaw - therapy | Quality of Life | Conservative Treatment | Laser Therapy - methods | Combined Modality Therapy | Lasers in surgery | Analysis | Therapeutics | Development and progression | Bones | Metastasis | Health aspects | Lasers in medicine | Homeopathy | Materia medica and therapeutics | Necrosis | Bone diseases | Disease management | Lasers | Index Medicus | Therapy | Searching | Medical services | Electronics | Osteonecrosis | Management | Disease control
Journal Article
Clinical oral implants research, ISSN 0905-7161, 01/2016, Volume 27, Issue 1, pp. 1 - 6
rat | zoledronic acid | ovariectomy | bisphosphonate‐related osteonecrosis of the jaws | periodontitis | Zoledronic acid | Bisphosphonate-related osteonecrosis of the jaws | Ovariectomy | Periodontitis | Rat | Engineering | Life Sciences & Biomedicine | Technology | Dentistry, Oral Surgery & Medicine | Engineering, Biomedical | Science & Technology | Alveolar Bone Loss - etiology | Periodontal Diseases - complications | Alveolar Bone Loss - prevention & control | Imidazoles - administration & dosage | Rats | Diphosphonates - administration & dosage | Imidazoles - pharmacology | Random Allocation | Rats, Sprague-Dawley | X-Ray Microtomography | Disease Progression | Periodontal Diseases - drug therapy | Animals | Female | Bisphosphonate-Associated Osteonecrosis of the Jaw - etiology | Diphosphonates - pharmacology | Disease Models, Animal | Bones | Density | Necrosis | Dentistry
Journal Article
Journal of veterinary internal medicine, ISSN 0891-6640, 03/2019, Volume 33, Issue 2, pp. 862 - 867
hypercalcemia | osteomyelitis | pamidronate | aminobisphosphonate | alendronate | bisphosphonate‐related osteonecrosis of the jaw | bisphosphonate-related osteonecrosis of the jaw | Life Sciences & Biomedicine | Veterinary Sciences | Science & Technology | Cats | Cat Diseases - drug therapy | Oral Ulcer - etiology | Cat Diseases - chemically induced | Bisphosphonate-Associated Osteonecrosis of the Jaw - veterinary | Alendronate - therapeutic use | Alendronate - adverse effects | Animals | Bisphosphonate-Associated Osteonecrosis of the Jaw - pathology | Bisphosphonate-Associated Osteonecrosis of the Jaw - therapy | Diphosphonates - therapeutic use | Female | Hypercalcemia - drug therapy | Hypercalcemia - veterinary | Oral Ulcer - veterinary | Diphosphonates - adverse effects | Bones | Alendronate | Disodium pamidronate | Necrosis | Drugs | Jaw | Edema | Mucosa | Neutrophils | Osteonecrosis | Bisphosphonates | Hypercalcemia | Biomedical materials | Histopathology | Antibiotics | Biopsy | Bone density | SMALL ANIMAL | Case Report
Journal Article
Oral oncology, ISSN 1368-8375, 2011, Volume 48, Issue 4, pp. 349 - 354
Otolaryngology | Hematology, Oncology and Palliative Medicine | Jaw | Tooth extraction | Osteonecrosis | BRONJ | Bisphosphonates | Bisphosphonate-related osteonecrosis | Oncology | Life Sciences & Biomedicine | Dentistry, Oral Surgery & Medicine | Science & Technology | Biological and medical sciences | Medical sciences | Otorhinolaryngology. Stomatology | Pharmacology. Drug treatments | Bones, joints and connective tissue. Antiinflammatory agents | Tumors | Injections, Intravenous | Prospective Studies | Bone Density Conservation Agents - adverse effects | Administration, Oral | Humans | Male | Treatment Outcome | Diphosphonates - administration & dosage | Bone Density Conservation Agents - administration & dosage | Tooth Extraction | Female | Diphosphonates - adverse effects | Bisphosphonate-Associated Osteonecrosis of the Jaw - prevention & control | Bisphosphonate-Associated Osteonecrosis of the Jaw - surgery | Prevention | Bones | Phosphonates | Necrosis | Mandible | Hospitals | Intravenous administration | Surgery | Teeth | Data processing | Statistics | Index Medicus
Journal Article